Breast cancer local therapy: What is its effect on mortality?

World Journal of Surgery

Volumn 36, Issue 7, 2012, Pages 1460-1474

  Benson, John R ^a,b,c   Teo, Katy A T ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; BREAST TUMOR; FEMALE; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; METASTASIS; MORTALITY; PATHOLOGY; REVIEW; SEGMENTAL MASTECTOMY; SURVIVAL RATE; TUMOR RECURRENCE;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 84864280372     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1468-5     Document Type: Article

References (76)

1. Fisher B, Anderson S, Fisher ER et al (1991) Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 3 38:327-331
2. Veronesi U, Marubini E, Del Vecchio M et al (1995) Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events. J Natl Cancer Inst 87:19-27
3. Komoike Y, Akiyama F, Lino Y et al (2005) Ipsilateral breast tumour recurrence (IBTR) after breast conserving treatment for breast cancer. Cancer 106:35-39
4. Wapnir IL, Anderson SJ, Mamounas EP et al (2006) Prognosis after ipsilateral breast tumour recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 24:2028-2036
5. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials. Lancet 366: 2087-2106
6. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747-752
7. Halsted WS (1898) The results of radical operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Ann Surg 20:455-497
8. Hellman S (1994) Natural history of small breast cancers. J Clin Oncol 12:2229-2234 (Pubitemid 24356043)
9. Rosen PP, Groshen S, Saigo PE et al (1989) A long term follow up study of survival in stage I (T1M0) and stage II (T1N1) breast carcinoma. J Clin Oncol 7:355-366
10. Cancer Research UK. Available at: http://info.cancerresearchuk. or/cancerstats. Accessed Mar 2011
11. Urban JA (1952) Radical mastectomy in continuity with en bloc resection of the internal mammary lymph node chain. Cancer 5:992-1008
12. Veronesi U, Marubini E, Mariani L et al (1999) The dissection of internal mammary nodes does not improve the survival of breast cancer patients. Eur J Cancer 35:1320-1325 (Pubitemid 29397430)
13. Gotzsche PC, Nielsen M (2006) Screening for breast cancer with mammography. Cochrane Database Syst Rev 3:CD 001877h
14. Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Eng J Med 353:1784-1792 (Pubitemid 41549890)
15. Kalager M, Zelen M, Langmark F et al (2010) Effect of screening mammography on breast cancer mortality in Norway. N Engl J Med 363:1203-1210
16. Baum M, Benson JR (1996) Current and future roles of adjuvant endocrine therapy in management of early carcinoma of the breast. Recent Results Cancer Res 140:215-226
17. Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241 (Pubitemid 35176242)
18. Haffty BG, Reiss M, Beinfield M et al (1996) Ipsilateral breast tumour recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52-57 (Pubitemid 26019996)
19. Komoike Y, Akiyama F, Iino Y et al (2006) Ipsilateral breast tumour recurrence (IBTR) after breast conserving treatment for early breast cancer: Risk factors and impact on distant metastases. Cancer 106:35-41 (Pubitemid 43032546)
20. Benson JR, della Rovere GQ (2008) Ipsilateral breast cancer recurrence. Breast 17:12-18
21. Fisher B, Joeng J-H, Anderson S et al (2002) Twenty-five year follow up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med 347:567-575
22. Overgaard M, Hansen PS, Overgaard J et al (1997) Post-operative radiotherapy in high risk pre-menopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949-955 (Pubitemid 27425950)
23. Ragaz J, Jackson SM, Le N et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962 (Pubitemid 27425951)
24. Vinn-Hung V, Verschraegen C (2004) Breast conserving surgery with or without radiotherapy: Pooled analysis for risks of ipsi-lateral breast tumour recurrence and mortality. J Natl Cancer Inst 96:115-121 (Pubitemid 38195902)
25. Whelan TJ, Lada BM, Laukkanen E et al (1997) Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Cancer Prev Control 1:228-240 (Pubitemid 28222404)
26. Early Breast Cancer Trialists' Collaborative Group (2000) Favourable and unfavourable effects on long-term survival for early breast cancer: an overview of the randomized trials. Lancet 355:1757-1770
27. Vinh-Hung V, Burzykowski T, Van de Steene J et al (2002) Postsurgery radiation in early breast cancer: Survival analysis of registry data. Radiother Oncol 64:281-290 (Pubitemid 35254021)
28. Kyndi M, Overgaard M, Nielsen HM et al (2009) High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c. Radiother Oncol 90:74-79
29. The Supremo Trial (2011) Available at www.supremo-trial.com. Accessed Mar 2011
30. Demechelli R, Valagussa P, Bonadonna G (2002) Double peaked time distribution of mortality of breast cancer patients undergoing mastectomy. Breast Cancer Res Treat 75:127-134 (Pubitemid 34994948)
31. Fortin A, Larochelle M, Laverdiere J et al (1999) Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 17:101-109 (Pubitemid 29022383)
32. Benson JR, Querci della Rovere G (2002) Ipsilateral local recurrence of breast cancer: Determinant or indicator of poor prognosis? Lancet Oncol 3:183-187
33. Hellman S (1997) Stopping metastases at their source. N Engl J Med 337:996-997 (Pubitemid 27425957)
34. Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifen treated, node negative breast cancer. N Engl J Med 351:2817-2826 (Pubitemid 40051905)
35. Locker G, Sainsbury R, Cuzick J (2002) Breast surgery in the ATAC trial: Women in the United States are more likely to have mastectomy. Breast Cancer Res Treat 76:S35
36. Schnitt SJ, Abner A, Gelman R et al (1994) The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74:1746-1751 (Pubitemid 24301829)
37. Ryoo MC, Kagan AT, Wollin M et al (1989) Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma. Radiology 172:555-559 (Pubitemid 19184905)
38. Kurtz JM, Jacquemir J, Amalric R et al (1990) Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 65:1867-1878 (Pubitemid 20116664)
39. Boger J, Kemperman H, Hart A et al (1994) Risk factors in breast conservation therapy. J Clin Oncol 12:653-660 (Pubitemid 24110901)
40. Di Biase S, Komarnicky LT, Schwartz GF et al (1988) The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 82:2212-2220
41. Schmidt-Ulrich R, Wazer D, Tercilla O et al (1989) Tumour margin assessment as a guide to optimal conservation surgery and irradiation in early-stage breast carcinoma. Int J Radiat Oncol Biol Phys 17:733-738 (Pubitemid 19250525)
42. Solin LJ, Fowble BL, Schultz DJ et al (1991) The significance of the pathology margins of the tumour excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 21:279-287
43. Schnitt SJ (2003) Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Am J Clin Pathol 120:485-488 (Pubitemid 37186043)
44. Mirza NQ, Vlastos G, Meric F et al (2002) Predictors of loco-regional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 9:256-265 (Pubitemid 34298630)
45. Wallgren A, Bonetti M, Gelber RD et al (2003) Risk factors for locoregional recurrence among breast cancer patients: Results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 21:1205-1213 (Pubitemid 46606395)
46. Park CC, Mitsumori M, Nixon A et al (2000) Outcome at 8 years after breast conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668-1675 (Pubitemid 30220545)
47. Sanghani M, Truong PT, Taad RA et al (2010) Validation of a web-based predictive nomogram for ipsilateral breast tumour recurrence after breast conservation treatment. J Clin Oncol 28:718-722
48. Kyndi M, Sorensen FB, Knudsen H et al (2008) Estrogen receptor, progesterone receptor, HER2 and response to postmastectomy radiotherapy in high risk breast cancer: The Danish Breast Cancer Cooperative Group. J Clin Oncol 26:1419-1426
49. Nguyen PL, Taghian AG, Katz MS et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor and HER2 is associated with local and distant recurrence after breast conserving therapy. J Clin Oncol 26:2373-2378
50. Smitt MC, Nowels K, Carlson RW et al (2003) Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys 57:979-985 (Pubitemid 37324115)
51. Petersen ME, Schultz DJ, Reynolds C et al (1999) Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: The University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 43:1029-1035 (Pubitemid 29144790)
52. Wazer DE, Schmidt-Ulrich RK, Ruthazer R et al (1998) Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumour bed. Int J Radiat Oncol Biol Phys 40:851-858 (Pubitemid 28150803)
53. Freedman G, Fowble B, Hanlon A et al (1999) Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44:1005-1015 (Pubitemid 29342901)
54. Taghian A, Mohiuddin M, Jagsi R et al (2005) Current perceptions regarding surgical margin status after breast conserving therapy: Results of a survey. Ann Surg 241:629-639 (Pubitemid 40397311)
55. Young OE, Valassiadou K, Dixon M (2007) A review of current practices in breast conservation surgery in the UK. Surg Oncol 89:118-123 (Pubitemid 46390650)
56. Ward ST, Jones BG, Jewkes AJ (2010) A two millimeter free margin from invasive tumour minimizes residual disease in breast conserving surgery. Int J Clin Pract 64:1675-1680
57. Moore MM, Borossa G, Imbrie JZ et al (2000) Association of infiltrating lobular carcinoma with positive surgical margins after breast conservation therapy. Ann Surg 231:877-882 (Pubitemid 30350246)
58. Dillon MF, Hill AD, Fleming FJ et al (2006) Identifying patients at risk of compromising margins following breast conservation for lobular carcinoma. Am J Surg 191:201-205 (Pubitemid 43151267)
59. Dillon MF, Hill ADK, Quinn CM et al (2006) A pathological assessment of adequate margin status in breast conserving surgery. Ann Surg Oncol 13:333-339 (Pubitemid 43255916)
60. Liau S-S, Cariati M, Noble D et al (2010) Audit of local recurrence following breast conservation surgery with 5 mm target margin and 40-gray breast radiotherapy for invasive breast cancer. Ann R Coll Surg Engl 92:562-568
61. Morrow M, Schmidt R, Hassett C (1995) Patient selection for breast conservation therapy with magnification mammography. Surgery 118:621-626
62. Pittinger TP, Maronian NC, Poulter CA et al (1994) Importance of margin status in outcome of breast conserving surgery for carcinoma. Surgery 116:605-609 (Pubitemid 24314202)
63. Forouhi P, Brahmbhatt DH, Benson JR et al. (2009) Breast conservation: factors predictive of residual disease following reoperation for narrow surgical margins. Cancer Res 69(Suppl 1)
64. Singletary SE (2002) Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184:383-393 (Pubitemid 35335942)
65. Morrow M, Harris JR (2007) Practice guidelines for breast conserving therapy in the management of invasive breast cancer. J Am Coll Surg 205:362-376
66. Silverstein M, Lagios M, Groshen S et al (1999) The influence of margin width on local control of ductal carcinoma of the breast. N Engl J Med 340:1455-1461 (Pubitemid 29220544)
67. Dunne C, Burke JP, Morrow M et al (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27:1615-1620
68. NICE Clinical Guideline 80 (2009) Early and locally advanced breast cancer: diagnosis and treatment
69. Veronesi U, Volterrani F, Luini A et al (1990) Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26:671-673 (Pubitemid 20275097)
70. Asgeirsson K, McCulley S, Pinder S et al (2003) Size of invasive breast cancer and risk of local recurrence after breast conserving therapy. Eu J Cancer 39:2462-2469 (Pubitemid 37340160)
71. Van Dongen JA, Bartelink H, Fentimen I et al (1992) Factors influencing local relapse and survival and results of salvage treatment after breast conserving treatment in operable breast cancer. Eu J Cancer 28A:808-815
72. Fisher BJ, Perera FE, Cooke AL et al (1997) Long term follow up of axillary node positive breast cancer patients receiving adjuvant systemic therapy alone: Patterns of recurrence. Int J Radiat Oncol Biol Phys 38:541-550 (Pubitemid 27305015)
73. Clough KB, Lewis JS, Couturaud B et al (2003) Oncoplastic techniques allow extensive resection for breast conserving therapy of breast carcinomas. Ann Surg 237:26-34 (Pubitemid 36622314)
74. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of the randomized trials. Lancet 365:1687-1717
75. Mamounas EP, Tang G, Fisher B et al (2010) Association between the 21-gene recurrence score assay and risk of loco-regional recurrence in node negative estrogen receptor positive breast cancer: Results from NSABP B-14 and NSABP B-20. J Clin Oncol 28:1677-1683
76. Giuliano AE, Hunt K, Ballman K et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastases: A randomized clinical trial. JAMA 305:569-575